Biofrontera (BFRIW) Cash from Financing Activities (2020 - 2025)

Biofrontera's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities fell 41.98% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $6.1 million (down 58.87% YoY), while the FY2025 annual figure was $10.8 million, down 26.86% from the prior year.
• Cash from Financing Activities was $2.4 million for Q4 2025 at Biofrontera, down from $4.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $43.8 million in Q4 2021 to a low of -$298000.0 in Q3 2024.
• Historically, Cash from Financing Activities has averaged $7.3 million across 5 years, with a median of $4.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 3926.45% in 2022, then plunged 150.42% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at $43.8 million in 2021, then slumped by 89.44% to $4.6 million in 2022, then surged by 45.01% to $6.7 million in 2023, then plunged by 39.68% to $4.0 million in 2024, then tumbled by 41.98% to $2.4 million in 2025.
• The last three Cash from Financing Activities figures came in at $2.4 million (Q4 2025), $4.0 million (Q4 2024), and -$298000.0 (Q3 2024), per Business Quant data.